Endocrinology

1. SGLT2 inhibitors reduced the risk of kidney disease progression by 37% overall, with comparable effects in patients with and...

1. In this randomized controlled trial, sustained low-carbohydrate diet in patients with untreated hemoglobin A1c of 6.0%-6.9% led to improved...

1. In this study, treatment with semaglutide at any of the 5 doses approved for long-term weight management led to...

1. Gonadotropin-releasing hormone analogue is not associated with subsequent gender affirming hormone use 2. Gonadotropin-releasing hormone analogue and its benefits...

1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring resulted in significantly lower glycated hemoglobin levels...

1. For sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists to be used as first-line agents for type...

1. In this systematic review and meta-analysis that included 16,597 patients, fine needle biopsy (FNB) sensitivity was approximately 86%, and...

1. This population-based cohort study demonstrated that among older adults with type 2 diabetes, sodium-glucose cotransporter-2 inhibitor (SGLT-2i) use was...

1. Polycystic ovarian syndrome (PCOS) diagnosis puts women at 1.9 times higher risk of pancreatic cancer 2. PCOS was an...

 1. In a prospective cohort study, low income was associated with an increase in body mass index (BMI) and cortisol levels...